Mechanically strong geopolymers offer new possibilities in treatment of chronic pain

Journal of Controlled Release

Volumn 146, Issue 3, 2010, Pages 370-377

  Jämstorp, Erik ^a   Forsgren, Johan ^a   Bredenberg, Susanne ^b   Engqvist, Håkan ^a   Strømme, Maria ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Orexo AB   (Sweden)

Author keywords

Abuse secured; Chronic pain; Fentanyl; Geopolymers; Opioids; Porous

Indexed keywords

ABUSE-SECURED; CHRONIC PAIN; FENTANYLS; GEOPOLYMERS; OPIOIDS; POROUS;

ANESTHETICS; CONTROLLED DRUG DELIVERY; DRUG DOSAGE; HEALTH; MECHANICAL PROPERTIES;

INORGANIC POLYMERS;

FENTANYL; KAOLIN; OPIATE DERIVATIVE; ZOLPIDEM;

ARTICLE; CHRONIC PAIN; CLAY; COMPRESSION; DIFFUSION COEFFICIENT; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; MATERIALS TESTING; PRIORITY JOURNAL;

ANALGESICS, OPIOID; CHRONIC DISEASE; COMPRESSIVE STRENGTH; DELAYED-ACTION PREPARATIONS; FENTANYL; HUMANS; HYPNOTICS AND SEDATIVES; KAOLIN; PAIN; POLYMERS; PYRIDINES;

EID: 77956288296     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.05.029     Document Type: Article

References (43)

1. Mercadante S., Bruera E. Opioid switching: a systematic and critical review. Cancer Treat. Rev. 2006, 32:304-315.
2. Riley J., Ross J.R., Rutter D., Shah S., Gwilliam B., Wells A.U., Welsh K. A retrospective study of the association between haematological and biochemical parameters and morphine intolerance in patients with cancer pain. Palliat. Med. 2004, 18:19-24.
3. Muijsers R.B.R., Wagstaff A.J. Transdermal fentanyl-an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs 2001, 61:2289-2307.
4. Jeal W., Benfield P. Transdermal fentanyl-a review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 1997, 53:109-138.
5. Simmonds M.A., Richenbacher J. Transdermal fentanyl-long-term analgesic studies. J. Pain Symptom Manage. 1992, 7:36-39.
6. Donner B., Zenz M., Tryba M., Strumpf M. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 1996, 64:527-534.
7. Jacobi J., Fraser G.L., Coursin D.B., Riker R.R., Fontaine D., Wittbrodt E.T., Chalfin D.B., Masica M.F., Bjerke H.S., Coplin W.M., Crippen D.W., Fuchs B.D., Kelleher R.M., Marik P.E., Nasraway S.A., Murray M.J., Peruzzi W.T., Lumb P.D. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit. Care Med. 2002, 30:119-141.
8. Cancer Pain Relief: With a Guide to Opioid Availability 1996, World Health Organization, Geneva. 2nd ed.
9. Sloan P., Babul N. Extended-release opioids for the management of chronic non-malignant pain. Expet. Opin. Drug Deliv. 2006, 3:489-497.
10. Callister W.D. Materials Science and Engineering: An Introduction 1997, John Wiley & Sons, Inc, New York.
11. Duxson P., Fernandez-Jimenez A., Provis J.L., Lukey G.C., Palomo A., van Deventer J.S.J. Geopolymer technology: the current state of the art. J. Mater. Sci. 2007, 42:2917-2933.
12. Duxson P., Provis J.L., Lukey G.C., Mallicoat S.W., Kriven W.M., van Deventer J.S.J. Understanding the relationship between geopolymer composition, microstructure and mechanical properties. Colloids Surf., Physicochem. Eng. Asp. 2005, 269:47-58.
13. Davidovits J. Geopolymers-inorganic polymeric new materials. J. Therm. Anal. 1991, 37:1633-1656.
14. Palomo A., Blanco-Varela M.T., Granizo M.L., Puertas F., Vazquez T., Grutzeck M.W. Chemical stability of cementitious materials based on metakaolin. Cem. Concr. Res. 1999, 29:997-1004.
15. Davidovits J., Morris M. The Pyramids: An Enigma Solved 1988, Dorset Press, New York.
16. Barsoum M.W., Ganguly A., Hug G. Microstructural evidence of reconstituted limestone blocks in the Great Pyramids of Egypt. J. Am. Ceram. Soc. 2006, 89:3788-3796.
17. Duxson P., Provis J.L., Lukey G.C., Van Deventer J.S.J. The role of inorganic polymer technology in the development of "green concrete". Cem. Concr. Res. 2007, 37:1590-1597.
18. Komnitsas K., Zaharaki D. Geopolymerisation: a review and prospects for the minerals industry. Miner. Eng. 2007, 20:1261-1277.
19. Kriven W.M., Bell J.L., Gordon M. Microstructure and microchemistry of fully-reacted geopolymers and geopolymer matrix composites. Ceram. Trans. 2003, 153:227-250.
20. ISO 5833:2002 Implants for surgery-acrylic resin cements.
21. Crank J. The Mathematics of Diffusion 1975, Clarendon Press, Oxford.
22. Chen J., Blevins W.E., Park H., Park K. Gastric retention properties of superporous hydrogel composites. J. Control. Release 2000, 64:39-51.
23. Streisand J.B., Varvel J.R., Stanski D.R., Lemaire L., Ashburn M.A., Hague B.I., Tarver S.D., Stanley T.H. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology 1991, 75:223-229.
24. Ranade V.V., Hollinger M.A., Cannon J.B. Drug Delivery Systems 2003, CRC Press Inc, Boca Raton.
25. Steveson M., Sagoe-Crentsil K. Relationships between composition, structure and strength of inorganic polymers. J. Mater. Sci. 2005, 40:2023-2036.
26. Rößler M., Odler I. Investigations on the relationship between porosity, structure and strength of hydrated portland cement pastes I. Effect of porosity. Cem. Concr. Res. 1985, 15:320-330.
27. Rice R.W., Dekker M. Porosity of Ceramics 1998, CRC, New York.
28. United States Pharmacopeia (USP). U.S. 1997, Pharmacopeial Convention Inc, Rockville.
29. Yuen K.H., Deshmukh A.A., Newton J.M., Short M., Melchor R. Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled-release formulation. Int. J. Pharm. 1993, 97:61-77.
30. Roy S.D., Flynn G.L. Solubility behavior of narcotic analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl, and sufentanil. Pharm. Res. 1989, 6:147-151.
31. Kydonieus A.F. Treatise on Controlled Drug Delivery: Fundamentals, Optimization, Applications 1992, Marcel Dekker, Inc., New York.
32. Brinker C.J., Scherer G.W. Sol-Gel Science: The Physics and Chemistry of Sol-Gel Processing 1990, Academic Press, Boston.
33. Rohrig T., Moore C. Zolpidem. Forensic Sci. Med. Pathol. 2005, 1:81-90.
34. Aulton M.E. Pharmaceutics: The Science of Dosage Form Design 2002, Churchill Livingstone, London.
35. Auerbach S.M., Carrado K.A., Dutta P.K. Handbook of Zeolite Science and Technology 2003, M. Dekker, New York.
36. Zhang H., Kim Y., Dutta P.K. Controlled release of paraquat from surface-modified zeolite Y. Microporous Mesoporous Mater. 2006, 88:312-318.
37. Bortnovsky O., Dedecek J., Tvaruzkova Z., Sobalik Z., Subrt J. Metal ions as probes for characterization of geopolymer materials. J. Am. Ceram. Soc. 2008, 91:3052-3057.
38. Fernandez-Jimenez A., Garcia-Lodeiro I., Palomo A. Durability of alkali-activated fly ash cementitious materials. J. Mater. Sci. 2007, 42:3055-3065.
39. Bakharev T. Resistance of geopolymer materials to acid attack. Cem. Concr. Res. 2005, 35:658-670.
40. Forsgren J., Jämstorp E., Bredenberg S., Engqvist H., Strømme M. A ceramic drug delivery vehicle for oral administration. J. Pharm. Sci. 2010, 99:219-226.
41. Oudadesse H., Derrien A., Lefloch M., Davidovits J. MAS-NMR studies of geopolymers heat-treated for applications in biomaterials field. J. Mater. Sci. 2007, 42:3092-3098.
42. Kralj M., Pavelic K. Medicine on a small scale-how molecular medicine can benefit from self-assembled and nanostructured materials. EMBO Rep. 2003, 4:1008-1012.
43. Vogel S. Comparative Biomechanics: Life's Physical World 2003, Princeton University Press, Princeton, NJ.